Citadel Advisors
IMGN

Citadel Advisors’s Immunogen Inc IMGN Stock Holding History

Citadel Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-285,000
Closed -$8.45M – 15808
2023
Q4 		$8.45M Sell
285,000
-400
-0.1% -$7.96K ﹤0.01% 3077
2023
Q3 		$4.53M Sell
285,400
-67,600
-19% -$1.12M ﹤0.01% 3820
2023
Q2 		$6.66M Sell
353,000
-46,600
-12% -$550K ﹤0.01% 3224
2023
Q1 		$1.53M Buy
399,600
+187,200
+88% +$798K ﹤0.01% 5871
2022
Q4 		$1.05M Buy
212,400
+44,400
+26% +$241K ﹤0.01% 6717
2022
Q3 		$803K Buy
168,000
+33,800
+25% +$178K ﹤0.01% 7470
2022
Q2 		$604K Sell
134,200
-284,900
-68% -$1.24M ﹤0.01% 8214
2022
Q1 		$2M Buy
419,100
+315,300
+304% +$1.75M ﹤0.01% 6086
2021
Q4 		$770K Sell
103,800
-25,200
-20% -$157K ﹤0.01% 8583
2021
Q3 		$731K Buy
129,000
+61,200
+90% +$354K ﹤0.01% 8948
2021
Q2 		$447K Sell
67,800
-71,100
-51% -$496K ﹤0.01% 10307
2021
Q1 		$1.13M Buy
138,900
+63,100
+83% +$515K ﹤0.01% 7814
2020
Q4 		$489K Buy
75,800
+54,300
+253% +$317K ﹤0.01% 8188
2020
Q3 		$77K Sell
21,500
-100
-0.5% -$404 ﹤0.01% 9419
2020
Q2 		$99K Sell
21,600
-5,000
-19% -$21.3K ﹤0.01% 9002
2020
Q1 		$91K Buy
26,600
+3,800
+17% +$16.6K ﹤0.01% 8689
2019
Q4 		$116K Sell
22,800
-14,500
-39% -$49.2K ﹤0.01% 8489
2019
Q3 		$90K Sell
37,300
-19,300
-34% -$51.2K ﹤0.01% 8535
2019
Q2 		$123K Sell
56,600
-92,400
-62% -$219K ﹤0.01% 8452
2019
Q1 		$404K Buy
149,000
+35,500
+31% +$154K ﹤0.01% 7149
2018
Q4 		$545K Buy
113,500
+71,500
+170% +$434K ﹤0.01% 6280
2018
Q3 		$398K Sell
42,000
-50,000
-54% -$481K ﹤0.01% 7083
2018
Q2 		$895K Buy
92,000
+7,100
+8% +$74.8K ﹤0.01% 5414
2018
Q1 		$893K Buy
84,900
+43,800
+107% +$433K ﹤0.01% 4992
2017
Q4 		$263K Sell
41,100
-6,400
-13% -$39.5K ﹤0.01% 6676
2017
Q3 		$363K Buy
47,500
+20,300
+75% +$135K ﹤0.01% 5781
2017
Q2 		$193K Sell
27,200
-4,900
-15% -$22.4K ﹤0.01% 6602
2017
Q1 		$124K Buy
+32,100
New +$93.7K ﹤0.01% 6778
2016
Q4 		– Sell
-26,400
Closed -$71K – 7999
2016
Q3 		$71K Buy
26,400
+11,300
+75% +$32.9K ﹤0.01% 6767
2016
Q2 		$47K Buy
15,100
+2,900
+24% +$18.2K ﹤0.01% 6424
2016
Q1 		$104K Buy
12,200
+1,600
+15% +$13.5K ﹤0.01% 6010
2015
Q4 		$144K Sell
10,600
-5,500
-34% -$67.7K ﹤0.01% 6257
2015
Q3 		$155K Buy
16,100
+5,000
+45% +$73.1K ﹤0.01% 6474
2015
Q2 		$160K Buy
11,100
+900
+9% +$9.88K ﹤0.01% 6595
2015
Q1 		$91K Sell
10,200
-10,100
-50% -$73.2K ﹤0.01% 6911
2014
Q4 		$124K Sell
20,300
-3,100
-13% -$28.3K ﹤0.01% 6457
2014
Q3 		$248K Buy
23,400
+6,300
+37% +$71.3K ﹤0.01% 5493
2014
Q2 		$203K Buy
17,100
+12,400
+264% +$156K ﹤0.01% 5554
2014
Q1 		$70K Buy
4,700
+400
+9% +$6.31K ﹤0.01% 6497
2013
Q4 		$63K Sell
4,300
-5,400
-56% -$83K ﹤0.01% 5914
2013
Q3 		$165K Sell
9,700
-700
-7% -$12.3K ﹤0.01% 4947
2013
Q2 		$173K Buy
+10,400
New +$169K ﹤0.01% 4788

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's IMGN Position: Q1 2024 in Review

Citadel Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 795,458 shares — an estimated $23.6M sold.

Citadel Advisors first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $23.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Citadel Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 795,458 Immunogen Inc shares in Q1 2024, an estimated $23.6M.
  • Citadel Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
  • Citadel Advisors's Immunogen Inc position peaked at $23.6M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.